Primary drug resistance to both rifampicin and dapsone in a paucibacillary leprosy patient.
Indian J Lepr
;
1988 Jan; 60(1): 90-2
Article
in English
| IMSEAR
| ID: sea-55423
ABSTRACT
A thirty-one year old male patient was diagnosed and treated for a pure or better primary neuritic case of leprosy with dapsone (100 mg daily for 2 years) and rifampicin (600 mg daily for 6 months). From the very outset, the patient did not show any improvement; on the top of it, he subsequently, developed a cutaneous patch, which on histopathological examination, revealed classical features of BT leprosy. Acid-fast bacilli were absent both in skin slit smear and histologic section. A primary resistance to both dapsone and rifampicin, even in paucibacillary patient, is speculated.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Rifampin
/
Humans
/
Male
/
Drug Resistance, Microbial
/
Leprosy, Tuberculoid
/
Adult
/
Dapsone
/
Drug Therapy, Combination
/
Mycobacterium leprae
Language:
English
Journal:
Indian J Lepr
Journal subject:
Tropical Medicine
Year:
1988
Type:
Article
Similar
MEDLINE
...
LILACS
LIS